Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer

Toshiyuki Ishiwata, Helmut Friess, Markus W. Büchler, Martha E. Lopez, Murray Korc

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Keratinocyte growth factor (KGF) is an angiogenic and mitogenic polypeptide that has been implicated in cancer growth and tissue development and repair. Its actions are dependent on its binding to a specific cell- surface KGF receptor (KGFR), which is encoded by the fibroblast growth factor (FGF) receptor type II (FGFR-2) gene. In the present study, we compared the immunohistochemical localization of KGF and KGFR/FGFR-2 in the normal and cancerous pancreas using specific antibodies that recognize KGF and KGFR/FGFR-2 and examined the expression of KGF, KGFR, and FGFR-2 in human pancreatic cancer by in situ hybridization with the corresponding riboprobes. In the normal pancreas, KGF immunoreactivity was present principally in the islet cells, whereas KGFR/FGFR-2 immunoreactivity was present both in the islet and ductal cells. In the pancreatic cancers, moderate KGF and moderate to strong KGFR/FGFR-2 immunoreactivity was present in many of the cancer cells. Furthermore, the ductal and acinar cells adjacent to the cancer cells exhibited moderate to strong KGF and KGFR/FGFR-2 immunoreactivtty. By in situ hybridization, KGF, KGFR, and FGFR-2 were overexpressed and co-localized in the cancer cells within the pancreatic tumor mass but were even more abundant in the acinar and ductal cells adjacent to the cancer cells. These findings indicate that KGF, KGFR, and FGFR-2 are overexpressed in both the cancer cells and the adjacent pancreatic parenchyma and raise the possibility that KGF may act in an autocrine and paracrine manner to enhance pancreatic cancer cell growth in vivo.

Original languageEnglish (US)
Pages (from-to)213-222
Number of pages10
JournalAmerican Journal of Pathology
Volume153
Issue number1
StatePublished - Jul 1998
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Fibroblast Growth Factor 7
Neoplasms
Acinar Cells
keratinocyte growth factor receptor
Islets of Langerhans
In Situ Hybridization
Pancreas
Fibroblast Growth Factor Receptors
Growth and Development

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Ishiwata, T., Friess, H., Büchler, M. W., Lopez, M. E., & Korc, M. (1998). Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. American Journal of Pathology, 153(1), 213-222.

Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. / Ishiwata, Toshiyuki; Friess, Helmut; Büchler, Markus W.; Lopez, Martha E.; Korc, Murray.

In: American Journal of Pathology, Vol. 153, No. 1, 07.1998, p. 213-222.

Research output: Contribution to journalArticle

Ishiwata, T, Friess, H, Büchler, MW, Lopez, ME & Korc, M 1998, 'Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer', American Journal of Pathology, vol. 153, no. 1, pp. 213-222.
Ishiwata, Toshiyuki ; Friess, Helmut ; Büchler, Markus W. ; Lopez, Martha E. ; Korc, Murray. / Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. In: American Journal of Pathology. 1998 ; Vol. 153, No. 1. pp. 213-222.
@article{9b6833bd0f704bb1a64c11a4b659926b,
title = "Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer",
abstract = "Keratinocyte growth factor (KGF) is an angiogenic and mitogenic polypeptide that has been implicated in cancer growth and tissue development and repair. Its actions are dependent on its binding to a specific cell- surface KGF receptor (KGFR), which is encoded by the fibroblast growth factor (FGF) receptor type II (FGFR-2) gene. In the present study, we compared the immunohistochemical localization of KGF and KGFR/FGFR-2 in the normal and cancerous pancreas using specific antibodies that recognize KGF and KGFR/FGFR-2 and examined the expression of KGF, KGFR, and FGFR-2 in human pancreatic cancer by in situ hybridization with the corresponding riboprobes. In the normal pancreas, KGF immunoreactivity was present principally in the islet cells, whereas KGFR/FGFR-2 immunoreactivity was present both in the islet and ductal cells. In the pancreatic cancers, moderate KGF and moderate to strong KGFR/FGFR-2 immunoreactivity was present in many of the cancer cells. Furthermore, the ductal and acinar cells adjacent to the cancer cells exhibited moderate to strong KGF and KGFR/FGFR-2 immunoreactivtty. By in situ hybridization, KGF, KGFR, and FGFR-2 were overexpressed and co-localized in the cancer cells within the pancreatic tumor mass but were even more abundant in the acinar and ductal cells adjacent to the cancer cells. These findings indicate that KGF, KGFR, and FGFR-2 are overexpressed in both the cancer cells and the adjacent pancreatic parenchyma and raise the possibility that KGF may act in an autocrine and paracrine manner to enhance pancreatic cancer cell growth in vivo.",
author = "Toshiyuki Ishiwata and Helmut Friess and B{\"u}chler, {Markus W.} and Lopez, {Martha E.} and Murray Korc",
year = "1998",
month = "7",
language = "English (US)",
volume = "153",
pages = "213--222",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer

AU - Ishiwata, Toshiyuki

AU - Friess, Helmut

AU - Büchler, Markus W.

AU - Lopez, Martha E.

AU - Korc, Murray

PY - 1998/7

Y1 - 1998/7

N2 - Keratinocyte growth factor (KGF) is an angiogenic and mitogenic polypeptide that has been implicated in cancer growth and tissue development and repair. Its actions are dependent on its binding to a specific cell- surface KGF receptor (KGFR), which is encoded by the fibroblast growth factor (FGF) receptor type II (FGFR-2) gene. In the present study, we compared the immunohistochemical localization of KGF and KGFR/FGFR-2 in the normal and cancerous pancreas using specific antibodies that recognize KGF and KGFR/FGFR-2 and examined the expression of KGF, KGFR, and FGFR-2 in human pancreatic cancer by in situ hybridization with the corresponding riboprobes. In the normal pancreas, KGF immunoreactivity was present principally in the islet cells, whereas KGFR/FGFR-2 immunoreactivity was present both in the islet and ductal cells. In the pancreatic cancers, moderate KGF and moderate to strong KGFR/FGFR-2 immunoreactivity was present in many of the cancer cells. Furthermore, the ductal and acinar cells adjacent to the cancer cells exhibited moderate to strong KGF and KGFR/FGFR-2 immunoreactivtty. By in situ hybridization, KGF, KGFR, and FGFR-2 were overexpressed and co-localized in the cancer cells within the pancreatic tumor mass but were even more abundant in the acinar and ductal cells adjacent to the cancer cells. These findings indicate that KGF, KGFR, and FGFR-2 are overexpressed in both the cancer cells and the adjacent pancreatic parenchyma and raise the possibility that KGF may act in an autocrine and paracrine manner to enhance pancreatic cancer cell growth in vivo.

AB - Keratinocyte growth factor (KGF) is an angiogenic and mitogenic polypeptide that has been implicated in cancer growth and tissue development and repair. Its actions are dependent on its binding to a specific cell- surface KGF receptor (KGFR), which is encoded by the fibroblast growth factor (FGF) receptor type II (FGFR-2) gene. In the present study, we compared the immunohistochemical localization of KGF and KGFR/FGFR-2 in the normal and cancerous pancreas using specific antibodies that recognize KGF and KGFR/FGFR-2 and examined the expression of KGF, KGFR, and FGFR-2 in human pancreatic cancer by in situ hybridization with the corresponding riboprobes. In the normal pancreas, KGF immunoreactivity was present principally in the islet cells, whereas KGFR/FGFR-2 immunoreactivity was present both in the islet and ductal cells. In the pancreatic cancers, moderate KGF and moderate to strong KGFR/FGFR-2 immunoreactivity was present in many of the cancer cells. Furthermore, the ductal and acinar cells adjacent to the cancer cells exhibited moderate to strong KGF and KGFR/FGFR-2 immunoreactivtty. By in situ hybridization, KGF, KGFR, and FGFR-2 were overexpressed and co-localized in the cancer cells within the pancreatic tumor mass but were even more abundant in the acinar and ductal cells adjacent to the cancer cells. These findings indicate that KGF, KGFR, and FGFR-2 are overexpressed in both the cancer cells and the adjacent pancreatic parenchyma and raise the possibility that KGF may act in an autocrine and paracrine manner to enhance pancreatic cancer cell growth in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0031872092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031872092&partnerID=8YFLogxK

M3 - Article

C2 - 9665482

AN - SCOPUS:0031872092

VL - 153

SP - 213

EP - 222

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -